BioRestorative Therapies, Inc.

DB:9OF Stock Report

Market Cap: €10.6m

BioRestorative Therapies Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

DB:9OF Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
28 Oct 24Sell€1,623Dale BroadrickIndividual1,112€1.46

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of 9OF?
Owner TypeNumber of SharesOwnership Percentage
Institutions281,9123.76%
Private Companies477,9726.37%
Hedge Funds665,4008.87%
Individual Insiders1,438,69419.2%
General Public4,640,80261.8%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 24 shareholders own 38.16% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
8.87%
Auctus Fund Management, LLC
665,400€937.2k-2.32%66.01%
8.59%
Todd Morrison
645,000€908.5k13.2%no data
6.37%
Fleetco, Inc.
477,972€673.2k0%no data
5.94%
Dale Broadrick
445,933€628.1k0%no data
2.29%
Lance Alstodt
171,872€242.1k0%no data
2.24%
Francisco Silva
167,895€236.5k0%no data
0.8%
Geode Capital Management, LLC
59,997€84.5k9.64%no data
0.68%
Sterne Agee Asset Management, Inc.
51,192€72.1k2.18%no data
0.53%
Wealth Alliance, LLC
40,000€56.3k0%0.03%
0.51%
Morgan Stanley, Investment Banking and Brokerage Investments
38,000€53.5k38.2%no data
0.4%
The Vanguard Group, Inc.
29,730€41.9k45.2%no data
0.27%
State Street Global Advisors, Inc.
20,459€28.8k0%no data
0.23%
U.S. Financial Advisors, LLC
17,142€24.1k0%0.01%
0.15%
Newman Dignan & Sheerar, Inc.
11,522€16.2k0%no data
0.11%
UBS Asset Management AG
8,346€11.8k-48.8%no data
0.11%
Robert Kristal
7,994€11.3k0%no data
0.043%
Tower Research Capital Europe Limited
3,197€4.5k103%no data
0.029%
Osaic Wealth, Inc. , Asset Management Arm
2,193€3.1k1,040%no data
0.00099%
SBI Holdings Inc., Asset Management Arm
74€104.623.3%no data
0.00057%
Bank of America Corporation, Asset Management Arm
43€60.32.38%no data
0.00016%
Rossby Financial, LLC
12€16.90%no data
0.00004%
Toronto-Dominion Bank, Banking Investments
3€4.250%no data
0.00001%
Parallel Advisors, LLC
1€1.10%no data
0.00001%
Cornerstone Planning Group Inc.
1€1.10%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/23 18:45
End of Day Share Price 2025/05/23 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

BioRestorative Therapies, Inc. is covered by 4 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jason McCarthyMaxim Group
Michael OkunewitchMaxim Group
Elemer PirosRoth Capital Partners